Christopher Locher
Chief Executive Officer Versatope Therapeutics
Seminars
Thursday 25th September 2025
Advancing Exosome-Based Therapies: From Bench to Bedside
11:00 am
- Overcoming current manufacturing challenges
- Innovating novel delivery mechanisms for enhanced efficacy
- Showcasing clinical trial data and future directions
NEW DATA!
